Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Metabolomic profiles significantly differed in critically ill patients with 25(OH)D ≤ 15 ng/ml relative to those with levels >15 ng/ml.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Secondary analysis.

Secondary analysis

Analyses existing study data; this paper is not automatically another independent trial.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Patients were not selected with regard to risk of death or any known metabolic feature.

Source: Methods.

We conducted a sub-analysis involving 65 RoCI patients who had been selected for metabolic profiling, and in whom plasma was available for measuring 25(OH)D levels (Additional file , Fig.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Metabolome alterations in severe critical illness and vitamin D status

Secondary analysis · Critical Care · 2017

Original publication title

Metabolome alterations in severe critical illness and vitamin D status

Jessica Lasky-Su; Amber Dahlin; Augusto A. Litonjua; Angela J. Rogers; Michael J. McGeachie; Rebecca M. Baron; Lee Gazourian; Diana Barragan-Bradford; Laura E. Fredenburgh; Augustine M. K. Choi; Kris M. Mogensen; Sadeq A. Quraishi; Karin Amrein; Kenneth B. Christopher

© The Author(s). 2017

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Vitamin D status is associated with differential metabolic profiles during critical illness. Glutathione and glutamate pathway metabolism, which play principal roles in redox regulation and immunomodulation, respectively, were significantly altered with vitamin D status.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Metabolic homeostasis is substantially disrupted in critical illness. Given the pleiotropic effects of vitamin D, we hypothesized that metabolic profiles differ between critically ill patients relative to their vitamin D status.

Source: Background

Abstract: What methods does the paper describe?

We performed a metabolomics study on biorepository samples collected from a single academic medical center on 65 adults with systemic inflammatory response syndrome or sepsis treated in a 20-bed medical ICU between 2008 and 2010. To identify key metabolites and metabolic pathways related to vitamin D status in critical illness, we first generated metabolomic data using gas and liquid chromatography mass spectroscopy. We followed this by partial least squares-discriminant analysis to identify individual metabolites that were significant. We then interrogated the entire metabolomics profile using metabolite set enrichment analysis to identify groups of metabolites and pathways that were differentiates of vitamin D status.

Finally we performed logistic regression to construct a network model of chemical-protein target interactions important in vitamin D status.

Source: Methods

Abstract: Electronic supplementary material

The online version of this article (doi:10.1186/s13054-017-1794-y) contains supplementary material, which is available to authorized users.

Source: Electronic supplementary material

Abstract: Results

Metabolomic profiles significantly differed in critically ill patients with 25(OH)D ≤ 15 ng/ml relative to those with levels >15 ng/ml. In particular, increased 1,5-anhydroglucitol, tryptophan betaine, and 3-hydroxyoctanoate as well as decreased 2-arachidonoyl-glycerophosphocholine and N-6-trimethyllysine were strong predictors of 25(OH)D >15 ng/ml. The combination of these five metabolites led to an area under the curve for discrimination for 25(OH)D > 15 ng/ml of 0.82 (95% CI 0.71 to 0.93). The metabolite pathways related to glutathione metabolism and glutamate metabolism are significantly enriched with regard to vitamin D status.

Source: Results

Abstract: Conclusion

Vitamin D status is associated with differential metabolic profiles during critical illness. Glutathione and glutamate pathway metabolism, which play principal roles in redox regulation and immunomodulation, respectively, were significantly altered with vitamin D status.

Source: Conclusion
Authors’ abstract

Background

Metabolic homeostasis is substantially disrupted in critical illness. Given the pleiotropic effects of vitamin D, we hypothesized that metabolic profiles differ between critically ill patients relative to their vitamin D status.

Methods

We performed a metabolomics study on biorepository samples collected from a single academic medical center on 65 adults with systemic inflammatory response syndrome or sepsis treated in a 20-bed medical ICU between 2008 and 2010. To identify key metabolites and metabolic pathways related to vitamin D status in critical illness, we first generated metabolomic data using gas and liquid chromatography mass spectroscopy. We followed this by partial least squares-discriminant analysis to identify individual metabolites that were significant. We then interrogated the entire metabolomics profile using metabolite set enrichment analysis to identify groups of metabolites and pathways that were differentiates of vitamin D status.

Finally we performed logistic regression to construct a network model of chemical-protein target interactions important in vitamin D status.

Results

Metabolomic profiles significantly differed in critically ill patients with 25(OH)D ≤ 15 ng/ml relative to those with levels >15 ng/ml. In particular, increased 1,5-anhydroglucitol, tryptophan betaine, and 3-hydroxyoctanoate as well as decreased 2-arachidonoyl-glycerophosphocholine and N-6-trimethyllysine were strong predictors of 25(OH)D >15 ng/ml. The combination of these five metabolites led to an area under the curve for discrimination for 25(OH)D > 15 ng/ml of 0.82 (95% CI 0.71 to 0.93). The metabolite pathways related to glutathione metabolism and glutamate metabolism are significantly enriched with regard to vitamin D status.

Conclusion

Vitamin D status is associated with differential metabolic profiles during critical illness. Glutathione and glutamate pathway metabolism, which play principal roles in redox regulation and immunomodulation, respectively, were significantly altered with vitamin D status.

Electronic supplementary material

The online version of this article (doi:10.1186/s13054-017-1794-y) contains supplementary material, which is available to authorized users.

Publication and source details

Original title: Metabolome alterations in severe critical illness and vitamin D status

Jessica Lasky-Su; Amber Dahlin; Augusto A. Litonjua; Angela J. Rogers; Michael J. McGeachie; Rebecca M. Baron; Lee Gazourian; Diana Barragan-Bradford; Laura E. Fredenburgh; Augustine M. K. Choi; Kris M. Mogensen; Sadeq A. Quraishi; Karin Amrein; Kenneth B. Christopher

Critical Care · 2017

© The Author(s). 2017https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Parker B. Francis foundationhttp://dx.doi.org/10.13039/100000002National Institutes of HealthP01 HL108801, R01 HL079904, and R01 HL112747R01 HL123915K12 HL089990K08 GM083207R01 HL091957, R01 HL112747, and P01 108801Lasky-Su Jessica McGeachie Michael J. Baron Rebecca M. Fredenburgh Laura E. Choi Augustine M. K. http://dx.doi.org/10.13039/100008454American Society for Parenteral and Enteral Nutrition Rhoads Research Foundationhttp://dx.doi.org/10.13039/100000057National Institute of General Medical SciencesR01 GM115774Choi Augustine M. K.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T23:09:20.103649+00:00

DOI: 10.1186/s13054-017-1794-y · PMC5532782